Insulet Corp (PODD)

37.53
1.23 3.39
NASDAQ : Health Care
Prev Close 36.30
Open 36.30
Day Low/High 36.05 / 37.61
52 Wk Low/High 23.94 / 40.21
Volume 716.38K
Avg Volume 661.10K
Exchange NASDAQ
Shares Outstanding 57.43M
Market Cap 2.07B
EPS -1.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Analysts' Actions -- Express Scripts, Lions Gate, Qorvo, Whole Foods and More

Analysts' Actions -- Express Scripts, Lions Gate, Qorvo, Whole Foods and More

Here are Friday's top research calls, including upgrades for Express Scripts and Lions Gate, and downgrades for Qorvo and Whole Foods.

Insulet To Webcast Investor Day On November 16, 2016

Insulet To Webcast Investor Day On November 16, 2016

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced it will host an Investor Day on November...

Insulet Reports Third Quarter 2016 Financial Results

Insulet Reports Third Quarter 2016 Financial Results

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for...

New Study Shows Majority Of Omnipod® Insulin Management System Users Report Significant Clinical And Quality Of Life Benefits

New Study Shows Majority Of Omnipod® Insulin Management System Users Report Significant Clinical And Quality Of Life Benefits

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the online publication...

Insulet Corporation Honors National Diabetes Awareness Month At The NASDAQ Stock Market Closing Bell Ceremony On November 1st

Insulet Corporation Honors National Diabetes Awareness Month At The NASDAQ Stock Market Closing Bell Ceremony On November 1st

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it is kicking off...

Insulet Announces Board And Management Changes

Insulet Announces Board And Management Changes

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced changes to the responsibilities of key...

Insulet Corporation To Announce Third Quarter 2016 Financial Results On November 3, 2016

Insulet Corporation To Announce Third Quarter 2016 Financial Results On November 3, 2016

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results...

Insulet Enrolls First Patients In Clinical Trial For Its Omnipod® Artificial Pancreas System

Insulet Enrolls First Patients In Clinical Trial For Its Omnipod® Artificial Pancreas System

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the first...

Insulet Announces Pricing Of Convertible Senior Notes Due 2021

Insulet Announces Pricing Of Convertible Senior Notes Due 2021

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), a leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that it has priced a...

Insulet Announces Private Offering Of Convertible Senior Notes

Insulet Announces Private Offering Of Convertible Senior Notes

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), a leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced its intention to...

Insulet To Establish Highly-Automated Manufacturing Operation In The United States

Insulet To Establish Highly-Automated Manufacturing Operation In The United States

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced plans to...

Insulet Announces Executive Appointments

Insulet Announces Executive Appointments

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the...

Short Interest Declines 10% For PODD

Short Interest Declines 10% For PODD

The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 504,358 share decrease in total short interest for Insulet Corp , to 4,492,960, a decrease of 10.09% since 07/29/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

PODD: Insiders vs. Shorts

PODD: Insiders vs. Shorts

The most recent short interest data was recently released for the 07/15/2016 settlement date, and Insulet Corp is one of the most shorted stocks of the Russell 3000, based on 9.39 "days to cover" versus the median component at 6.33. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Insider Bets Paying Off At PODD As New 52-Week High Reached

Insider Bets Paying Off At PODD As New 52-Week High Reached

In trading on Thursday, shares of Insulet Corp touched a new 52-week high of $43.48/share. That's a 81.62% rise, or $19.54 per share from the 52-week low of $23.94 set back on 02/12/2016.

Insulet Reports Second Quarter 2016 Financial Results

Insulet Reports Second Quarter 2016 Financial Results

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for...

Insulet Corporation To Present At Upcoming Investor Conferences

Insulet Corporation To Present At Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three...

12 Year Old Podder™ Trent Wright Exploring Omnipod's New Toby's T1D Tale Educational App. (Photo: Business Wire)

12 Year Old Podder™ Trent Wright Exploring Omnipod's New Toby's T1D Tale Educational App. (Photo: Business Wire)

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the introduction of...

Insulet Corporation To Announce Second Quarter 2016 Financial Results On August 3, 2016

Insulet Corporation To Announce Second Quarter 2016 Financial Results On August 3, 2016

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results...

New Data Demonstrate Benefits Of Insulet's Omnipod® System For People With Type 1 And Type 2 Diabetes

New Data Demonstrate Benefits Of Insulet's Omnipod® System For People With Type 1 And Type 2 Diabetes

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its Omnipod Insulin Management System (Omnipod System), today announced two online publications of new data in the Journal of...

Insulet Partners With Joslin Diabetes Center To Implement A Unique Training Certification For Insulet's Clinical Team

Insulet Partners With Joslin Diabetes Center To Implement A Unique Training Certification For Insulet's Clinical Team

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that almost 100 members of Insulet's...

Insulet To Present Omnipod® Clinical Studies On Type 1 And Type 2 Diabetes During The American Diabetes Association's 76th Scientific Sessions

Insulet To Present Omnipod® Clinical Studies On Type 1 And Type 2 Diabetes During The American Diabetes Association's 76th Scientific Sessions

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced new clinical data...

Insider Trading Alert - PODD, POWI And SNSS Traded By Insiders

Insider Trading Alert - PODD, POWI And SNSS Traded By Insiders

Stocks with insider trader activity include PODD, POWI and SNSS

Insulet Launches New Omnipod® Podder™ Community Platform

Insulet Launches New Omnipod® Podder™ Community Platform

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the launch of a new...

Insulet (PODD) Is Strong On High Volume Today

Insulet (PODD) Is Strong On High Volume Today

Trade-Ideas LLC identified Insulet (PODD) as a strong on high relative volume candidate

On Tap for Analysts: Boston Scientific, Ford, Western Digital

On Tap for Analysts: Boston Scientific, Ford, Western Digital

Here are Friday's top research calls, including downgrades for Ford, Synaptics and Western Digital, and an upgrade for Boston Scientific.